Dr. Kristina Stacey Buscaino, DO

Dr. Buscaino practices at Advanced Urology Institute in Oxford, Florida.

Dr. Buscaino's NPI, 1679966832, was assigned on March 12, 2015. Dr. Buscaino graduated from Touro University Nevada in 2015. Dr. Buscaino holds Florida license OS16573.

Dr. Buscaino's primary practice is Advanced Urology Institute, at 12109 County Rd 103, Oxford, FL 34484 in Sumter County. The practice phone is (352) 391-6494.

Dr. Buscaino's primary practice is Advanced Urology Institute in Oxford, Florida. Dr. Buscaino is also affiliated with Lee Memorial Hospital. The medical group on file is Advanced Urology Institute. Dmand AI also links Dr. Buscaino to 2 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Buscaino practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Buscaino's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Buscaino is board certified in urological surgery by the AOA Board of Surgery. Dr. Buscaino is licensed in Florida.

Dmand AI lists bladder disease, enlarged prostate, erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease, pelvic prolapse and prostate cancer among the conditions Dr. Buscaino treats.

CMS data shows 7,646 Medicare services from Dr. Buscaino across 39 procedure codes in 2024, for 1,243 Medicare patients. Medicare paid $340,797 for them.

CMS counts 1,243 Medicare patients who saw Dr. Buscaino in 2024. The largest group is 75 to 84, with 617 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Buscaino's median patient age at 71, with 28% women.

In 2024, Dr. Buscaino wrote 1,383 Medicare Part D claims for 572 patients. 88% of them were for generic drugs. CMS names the drug for 1,231 of them, across 21 drugs with 11 or more claims each, at $178,822 in total drug cost. In 2023, CMS named 833 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Buscaino for performance year 2024, reported as part of a group. Dr. Buscaino accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Buscaino as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Buscaino in 2021. 2021 was the busiest year, with 3. The most frequent topics are Erectile Dysfunction, Penile Implantation and Patient Satisfaction. Dr. Buscaino has published most often in Curr Urol Rep. Dr. Buscaino's most frequent co-authors are Rafael E. Carrion, MD, Raul E. Fernandez-Crespo, MD and Justin Lewis Parker, MD.

CMS Open Payments shows 446 general payments to Dr. Buscaino from 47 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 79% of the total. Coloplast Corp paid the most, $5,463.

Dr. Buscaino graduated from Touro University Nevada in 2015.

Dr. Buscaino is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.